Quercetin + NMN: Sirtuin Activation and NAD+ Preservation Stack
Expert Summary
NAD+ levels decline 50% between age 20 and 60, primarily due to increased CD38 expression in aging immune cells. Quercetin is one of the most potent natural CD38 inhibitors identified, with IC50 values in the 10–50 μM range achievable with phytosome supplementation. Combined with NMN (which replenishes NAD+ via the salvage pathway), this creates a supply-and-demand NAD+ optimization stack.
Key Facts
- CD38 as the NAD+ drain: CD38 is a NAD+ glycohydrolase expressed in senescent immune cells and adipose tissue macrophages. With aging, CD38 expression increases dramatically, consuming NAD+ faster than it can be synthesized — explaining the age-related NAD+ decline.
- Quercetin IC50 for CD38: Quercetin inhibits CD38 at IC50 ~20 μM in cell culture. Quercetin phytosome achieves plasma concentrations approaching this range. Apigenin is an even more potent CD38 inhibitor (IC50 ~0.7 μM).
- NMN mechanism: NMN (nicotinamide mononucleotide) is the immediate precursor to NAD+ in the Preiss-Handler pathway. Oral NMN supplementation (250–500 mg/day) consistently raises blood NAD+ levels by 40–100% in human clinical studies.
- Sirtuin activation: Sirtuin enzymes (SIRT1, SIRT3, SIRT6) require NAD+ as a co-substrate. They regulate DNA repair (SIRT6), mitochondrial biogenesis (SIRT3), and inflammatory gene expression (SIRT1). Maintaining NAD+ preserves sirtuin activity that declines with age.
- Protocol: NMN 250–500 mg in the morning (on empty stomach for optimal absorption); quercetin phytosome 200–300 mg with breakfast. No timing conflict; both can be taken at the same time.
- Fisetin addition: Adding fisetin burst dosing monthly completes the triple stack — NMN (supply), quercetin (reduce demand), fisetin (clear senescent cell NAD+ drains).
Recommended Products
Frequently Asked Questions
How much does the quercetin + NMN combination increase NAD+ vs NMN alone?
Human trial data for the combination does not yet exist. Mechanistically, quercetin should prevent CD38 from consuming the NAD+ that NMN produces, resulting in greater net NAD+ accumulation — but the magnitude is not quantified in humans.
Can I substitute NR (nicotinamide riboside) for NMN?
Yes. NR and NMN both effectively raise NAD+ levels; they differ in transport mechanisms (NR uses nucleoside transporters; NMN may use a different pathway). Both are appropriate. NR is typically lower cost per effective dose.
Is apigenin a better CD38 inhibitor than quercetin?
Apigenin has a lower IC50 for CD38 inhibition (0.7 μM vs 20 μM for quercetin). Quercetin provides additional benefits (senolytic, cardiovascular, anti-inflammatory) making it a more multifunctional choice.
Scientific References
- Camacho-Pereira J et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metabolism. 2016. PMID: 27304511
- Yoshino J et al. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metabolism. 2011. PMID: 21982712